In a landmark development for reproductive medicine in Saudi Arabia, the Bunan Center for Fertility and Women’s Health has announced the birth of the country’s first baby conceived using artificial intelligence during in vitro fertilization procedures.
The achievement, announced on Tuesday, April 21, 2026, coincides with Saudi Arabia’s designation of 2026 as the “Year of Artificial Intelligence.” The Bunan Center, part of Global Fertility, utilized an AI system to select sperm cells during intracytoplasmic sperm injection (ICSI) procedures, marking a significant advancement in assisted reproductive technologies within the kingdom.
The AI technology was specifically implemented to improve the accuracy of sperm selection in laboratory settings, particularly benefiting cases involving severe sperm deficiency, poor motility, or elevated DNA fragmentation markers. This innovation aligns with broader efforts to integrate artificial intelligence into healthcare services, supporting Saudi Vision 2030’s objectives for medical innovation and enhanced quality of therapeutic services.
Medical specialists have described the development as a notable advancement in the field of assisted reproductive techniques, reflecting the accelerating pace of Saudi Arabia’s investments in artificial intelligence across various sectors.
In a landmark development for reproductive medicine in Saudi Arabia, the Bunan Center for Fertility and Women’s Health has announced the birth of the country’s first baby conceived using artificial intelligence during in vitro fertilization procedures.
The achievement, announced on Tuesday, April 21, 2026, coincides with Saudi Arabia’s designation of 2026 as the “Year of Artificial Intelligence.” The Bunan Center, part of Global Fertility, utilized an AI system to select sperm cells during intracytoplasmic sperm injection (ICSI) procedures, marking a significant advancement in assisted reproductive technologies within the kingdom.
The AI technology was specifically implemented to improve the accuracy of sperm selection in laboratory settings, particularly benefiting cases involving severe sperm deficiency, poor motility, or elevated DNA fragmentation markers. This innovation aligns with broader efforts to integrate artificial intelligence into healthcare services, supporting Saudi Vision 2030’s objectives for medical innovation and enhanced quality of therapeutic services.
Medical specialists have described the development as a notable advancement in the field of assisted reproductive techniques, reflecting the accelerating pace of Saudi Arabia’s investments in artificial intelligence across various sectors.
